Why us? Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

Author Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making.

MD MRCGP DFFP
Was this answer helpful?
Authored and medically reviewed by Dr Farzana Khan on 2 July 2026
Rate Dr Farzana's explanation



Consent first


Alternatives


Compare fairly

Women’s Health Clinic FAQ

What should informed consent include for energy treatments?

Energy-based treatment should be discussed alongside uncertainty, alternatives, aftercare and what pelvic-floor rehabilitation can and cannot do.

Direct answer

Informed consent for energy treatments should include expected benefits, uncertainty, alternatives, risks, aftercare, adverse events and what to do if symptoms worsen. The safest interpretation compares options by goal, evidence, risk, effort, suitability and follow-up.

A balanced answer compares pathways by goal, evidence, risk, effort, suitability and follow-up rather than convenience alone.


Educational only. Suitability and next steps should be confirmed after consultation. Results vary. Not a cure.

Women's Health Clinic consultation about what should informed consent include for energy treatments?

Informed choice

At a glance

These are the main points to understand before accepting a device, clinic, safety or comparison claim.

At a glance

Device-aware summary

Main area

Consent and alternatives

Pattern

Shared decision

Watch for

Underplayed uncertainty

Next step

Compare pathways

Important safety note

Consent should include expected benefits, limits, uncertainty, alternatives, adverse events, aftercare and what to do if symptoms worsen.

Consent
Alternatives
Evidence
Follow-up
Assessment




Detailed answer

Detailed answer

The deeper answer starts by separating device features, marketing claims, clinical governance, operator training, consent, safety and patient-relevant outcomes.

Informed consent

The reader wants to know whether a device feature, brand, clinic setting or treatment comparison is medically meaningful, and how to separate genuine safety governance from marketing.

Device
Safety
Evidence
Consent

Informed consent

Start with the clinical question being asked, not the device feature being advertised.

Alternatives

Check whether the claim is supported by patient-relevant outcomes, safety reporting and follow-up.

Pelvic-floor pathway

Ask how assessment, operator training, governance, infection control and aftercare are handled.

Evidence uncertainty

Compare alternatives by goal, evidence, risk, effort and suitability rather than convenience or brand language alone.

How the research shapes the answer

The research supports treating this as a consent and alternatives question rather than a generic device-feature claim.

The research synthesis shaped the structure, while final wording avoids device hype, treatment ranking, legal advice, operational parameters and overconfident benefit claims.





Patient safety

Why this matters

Device features can sound reassuring or impressive, but patients need to know whether those features translate into safer, more appropriate care.

It makes consent meaningful

Consent should explain uncertainty, alternatives and adverse events.

It compares different pathways fairly

Devices and physiotherapy work through different mechanisms.

It matches goals to care

Support, strength, comfort and confidence may need different routes.

It protects follow-up

Patients should know what improvement and worsening look like.

Governance protects choice

A cautious device discussion does not dismiss treatment; it helps match the option to the right clinical goal.

The strongest decision is one where benefits, limits, risks, alternatives, aftercare and escalation routes are all visible before treatment.





Considerations

What to consider

A consultation should connect symptoms, goals, device governance, operator training, infection control, consent, alternatives and follow-up.

Consultation priorities

Bring your symptoms, childbirth and menopause history, pelvic-floor symptoms, pain, urinary or bowel symptoms, previous treatments, goals and questions about device governance.

Goal
Governance
Safety
Alternatives

Ask about alternatives

Conservative care, pelvic-health review and procedural options may differ.

Ask what benefit is realistic

The goal should be specific and patient-relevant.

Ask what risks are known

Pain, burns, worsening symptoms and dissatisfaction should be covered.

Ask follow-up plan

Review and escalation should be clear before treatment.

What not to assume

Do not assume newer, faster, stronger, branded or automated treatment is automatically safer or better.

Treatment Protocol: A standard therapeutic course involves three brief outpatient sessions (5-10 minutes each) spaced 4 to 6 weeks apart [12, 13]. Short-Term Relief: Multiple observational cohorts report notable symptom improvement (reduced dryness and pain) persisting for 12 to 18 months post-treatment.





Common concerns and myths

Common misconceptions

These corrections keep the answer clinically cautious and useful rather than device-led.

Myth: Consent is just a form

Reality: informed consent and fair comparison require benefits, limits, risks, alternatives and follow-up.

Myth: Pelvic-floor rehabilitation and devices work the same way

Reality: the answer depends on assessment, device governance, operator training, consent, alternatives and follow-up.

Myth: Convenience is the main way to compare options

Reality: planning tools require clinician oversight and should not turn patients into device operators.

Features are not outcomes

A device feature can support treatment delivery, but patient benefit still depends on assessment, suitability, evidence and follow-up.

Uncertainty should be visible

Clear uncertainty helps patients compare device treatment, pelvic-health care, conservative options and referral pathways fairly.





Safety checklist

Safety checklist

Use these checks before accepting a device claim or deciding whether symptoms can wait for routine review.

Is the clinical goal clear?

Know whether the aim is comfort, support, friction, confidence, urinary symptoms, pain relief or another outcome.

Is governance clear?

Ask about device status, intended use, training, maintenance, infection control, aftercare and escalation routes.

Were alternatives discussed?

Pelvic-health assessment, symptom treatment, conservative care and procedural options may have different roles.

Are red flags present?

Bleeding, severe pain, fever, discharge, urinary retention, faecal incontinence or a new bulge should change the pathway.

More reassuring signs

The situation is more reassuring when symptoms are stable, there are no red flags, goals are realistic, governance is clear and follow-up is planned.

Stable
Governed
Reviewed

Reasons to seek advice

Consent should include expected benefits, limits, uncertainty, alternatives, adverse events, aftercare and what to do if symptoms worsen.

Bleeding
Pain
Discharge




When to escalate

When to seek medical help

These symptoms should not be managed with general device or vaginal-tightening advice alone.

Use NHS 111 online

Bleeding that needs review

Postmenopausal bleeding, bleeding after sex or unexplained bleeding should be assessed promptly.

Severe or worsening pain

Severe pelvic, vulval or vaginal pain, rapidly worsening symptoms or pain after treatment needs medical advice.

Infection or support symptoms

Fever, offensive discharge, urinary retention, faecal incontinence, a new bulge or marked pelvic pressure should be checked.

Emergency symptoms

Call 999 for life-threatening symptoms such as collapse, severe bleeding, chest pain, breathing difficulty or stroke-like symptoms.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

Additional clinical context

How to use this answer

Use this page to prepare a focused discussion about device claims, safety controls, governance, treatment goals and alternatives. The aim is to ask whether the feature being promoted is relevant to your symptoms and supported by patient-relevant evidence.

What to bring to consultation

Helpful details include childbirth history, menopause status, urinary or bowel symptoms, prolapse sensations, pain, dryness, previous procedures, infection concerns, what changed over time and what improvement would feel meaningful enough to justify treatment.

Next step

Book a clinical consultation

A consultation can compare device treatment, pelvic-health care, conservative options and follow-up so the plan matches the actual goal.

View Research Sources (12 Sources)
• GMC - Decision making and consent
• NICE - Transvaginal laser therapy for urogenital atrophy
• RCOG - Pelvic floor health
• POGP - Pelvic health physiotherapy
• PubMed - informed consent energy based vaginal devices
• PubMed - pelvic floor physiotherapy versus vaginal device treatment
• GOV.UK - Medical devices regulation and safety
• MHRA - Report a medical device problem
• ACOG - Elective female genital cosmetic surgery
• NICE NG123 - Urinary incontinence and pelvic organ prolapse
• NHS England - National infection prevention and control manual
• NICE - Evidence standards framework

These 12 source names are selected from 12 display-ready sources, with a raw audit trail of 62 imported records. Additional reviewed material included UK clinical guidance, professional society guidance, peer-reviewed clinical papers; duplicate, low-relevance and non-clinical records were removed before display.

Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.

  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.